Suchergebnisse - "Steenhuis, Maurice"

PubPharm (11)

1

Post COVID-19 condition imposes significant burden in patients with advanced chronic kidney disease : A nested case-control study

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2024

von Bouwmans, P. | Malahe, S. | Messchendorp, A. | +16

2

Longitudinal increase of humoral responses after four SARS-CoV-2 vaccinations and infection in MS patients on fingolimod

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2024

von van Kempen, Z. | van Dam, K. | Keijser, J. | +11

3

Longitudinal rheumatoid factor autoantibody responses after SARS-CoV-2 vaccination or infection

enthalten in: Frontiers in immunology | 2024

von Keijzer, S. | Oskam, N. | Ooijevaar-de Heer, P. | +14

4

Incidence and Severity of COVID-19 in Relation to Anti-Receptor-Binding Domain IgG Antibody Level after COVID-19 Vaccination in Kidney Transplant Recipients

enthalten in: Viruses | 2024

von Messchendorp, A. | Sanders, J. | Abrahams, A. | +14

5

Ocrelizumab Concentration Is a Good Predictor of SARS-CoV-2 Vaccination Response in Patients with Multiple Sclerosis

enthalten in: Annals of neurology | 2023

von van Kempen, Z. | Hogenboom, L. | Toorop, A. | +16

6

The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylated IgG1 in naive but not in antigen-experienced vaccinees

enthalten in: EBioMedicine | 2023

von Van Coillie, J. | Pongracz, T. | Rahmöller, J. | +68

7

Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations

enthalten in: Journal of autoimmunity | 2023

von van Dam, K. | Wieske, L. | Stalman, E. | +56

8

Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases

enthalten in: Annals of the rheumatic diseases | 2022

von Stalman, E. | Wieske, L. | van Dam, K. | +57

9

Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or Fingolimod

enthalten in: Neurology(R) neuroimmunology & neuroinflammation | 2022

von Palomares Cabeza, V. | Kummer, L. | Wieske, L. | +19

ErratumIn: Neurol Neuroimmunol Neuroinflamm. 2022 Aug 26;9(6):. - PMID 36028312

10

Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases

enthalten in: BMC medicine | 2022

von Wieske, L. | Kummer, L. | van Dam, K. | +51